GSA CAPITAL PARTNERS LLP - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 51 filers reported holding REGULUS THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2017$255,000
+83.5%
203,815
+44.8%
0.02%
+88.9%
Q2 2017$139,000
+39.0%
140,715
+877.8%
0.01%
+50.0%
Q1 2016$100,000
+6.4%
14,391
+13.3%
0.01%
-14.3%
Q4 2013$94,00012,7000.01%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
RA Capital Management 4,039,823$26,420,0003.79%
Foresite Capital Management II, LLC 1,750,269$11,447,0003.48%
ARGONAUT CAPITAL MANAGEMENT CORP 75,000$491,0001.65%
Abingworth LLP 327,350$2,138,0001.25%
Trellus Management Company, LLC 100,000$654,0000.96%
Cormorant Asset Management, LP 896,522$5,863,0000.94%
DAFNA Capital Management LLC 90,000$589,0000.58%
ORACLE INVESTMENT MANAGEMENT INC 749,064$4,898,0000.50%
Foresite Capital Management II, LLC 250,000$1,635,0000.50%
Foresite Capital Management II, LLC 250,000$1,635,0000.50%
View complete list of REGULUS THERAPEUTICS INC shareholders